1. Home
  2. CTNM vs COE Comparison

CTNM vs COE Comparison

Compare CTNM & COE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTNM
  • COE
  • Stock Information
  • Founded
  • CTNM 2009
  • COE 2011
  • Country
  • CTNM United States
  • COE Singapore
  • Employees
  • CTNM N/A
  • COE N/A
  • Industry
  • CTNM
  • COE Other Consumer Services
  • Sector
  • CTNM
  • COE Real Estate
  • Exchange
  • CTNM Nasdaq
  • COE Nasdaq
  • Market Cap
  • CTNM 248.7M
  • COE 271.9M
  • IPO Year
  • CTNM 2024
  • COE 2016
  • Fundamental
  • Price
  • CTNM $12.36
  • COE $47.79
  • Analyst Decision
  • CTNM Strong Buy
  • COE
  • Analyst Count
  • CTNM 4
  • COE 0
  • Target Price
  • CTNM $22.75
  • COE N/A
  • AVG Volume (30 Days)
  • CTNM 278.0K
  • COE 16.8K
  • Earning Date
  • CTNM 11-05-2025
  • COE 09-03-2025
  • Dividend Yield
  • CTNM N/A
  • COE N/A
  • EPS Growth
  • CTNM N/A
  • COE N/A
  • EPS
  • CTNM N/A
  • COE N/A
  • Revenue
  • CTNM N/A
  • COE $68,928,000.00
  • Revenue This Year
  • CTNM N/A
  • COE N/A
  • Revenue Next Year
  • CTNM N/A
  • COE N/A
  • P/E Ratio
  • CTNM N/A
  • COE N/A
  • Revenue Growth
  • CTNM N/A
  • COE 93.05
  • 52 Week Low
  • CTNM $3.35
  • COE $12.98
  • 52 Week High
  • CTNM $20.30
  • COE $51.71
  • Technical
  • Relative Strength Index (RSI)
  • CTNM 73.06
  • COE 75.45
  • Support Level
  • CTNM $10.30
  • COE $45.70
  • Resistance Level
  • CTNM $13.26
  • COE $51.71
  • Average True Range (ATR)
  • CTNM 1.04
  • COE 3.24
  • MACD
  • CTNM 0.03
  • COE 0.89
  • Stochastic Oscillator
  • CTNM 77.13
  • COE 78.61

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

About COE 51Talk Online Education Group

51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.

Share on Social Networks: